Skip to main content
SK Bioscience Co.,Ltd logo

SK Bioscience Co.,Ltd — Investor Relations & Filings

Ticker · 302440 ISIN · KR7302440003 KO Manufacturing
Filings indexed 381 across all filing types
Latest filing 2025-12-26 Director's Dealing
Country KR South Korea
Listing KO 302440

About SK Bioscience Co.,Ltd

https://www.skbioscience.com/

SK Bioscience is a biopharmaceutical company focused on the research, development, manufacturing, and commercialization of vaccines and biological products. Spun off from SK Chemicals in 2018, the company develops its own pipeline of vaccines, including cell-culture-based influenza vaccines and a COVID-19 vaccine, utilizing its established R&D and production platforms. In addition to its proprietary products, SK Bioscience provides global Contract Development and Manufacturing Organization (CDMO) services, offering end-to-end support from process development to large-scale commercial manufacturing for international partners. The company is dedicated to promoting public health by providing innovative preventative solutions to address global health challenges.

Recent filings

Filing Released Lang Actions
최대주주등소유주식변동신고서
Director's Dealing Classification · 1% confidence The document is a 'Report of Change in Shareholding by Major Shareholders and Others' (최대주주등소유주식변동신고서) from SK Bioscience. It details specific changes in share ownership by company executives (specifically Ahn Jae-yong exercising stock options). This type of filing, which reports personal share transactions by company directors and executives, falls under the 'Director's Dealing' category.
2025-12-26 Korean
[기재정정]단일판매ㆍ공급계약체결
Capital/Financing Update Classification · 1% confidence The document is a regulatory filing from SK Bioscience regarding a 'Single Sale/Supply Contract' amendment. It details a correction to a previously filed contract (specifically extending the contract end date). Since this is a specific regulatory disclosure regarding a material contract amendment and does not fit into categories like financial reports, board changes, or shareholder meetings, it falls under the general regulatory filing category.
2025-12-23 Korean
연결재무제표기준영업(잠정)실적(공정공시)
Regulatory Filings
2025-11-03 Korean
기업설명회(IR)개최(안내공시)
Regulatory Filings
2025-11-03 Korean
기업설명회(IR)개최(안내공시)
Regulatory Filings
2025-10-23 Korean
기타안내사항(안내공시)
Regulatory Filings
2025-10-17 Korean

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.